Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Acetylcysteine Essential-Healthcare 600mg Effervescent Tablets -PA2130/002/001
- Claforan Powder for Solution for Injection 500mg - PA0540/037/002
- Denzapine 50mg/ml Oral Suspension - PA0126/235/005
- Fortum 1g Powder for Solution for Injection or Infusion - PA1077/007/002
- Macrolief 13.8mgPowder for Oral Solution - PA0711/224/001
- Mirap 45mg Tablet - PA0711/062/003
- Nebivolol Teva 5mg Tablets - PA0749/078/001
- Suboxone 2mg/0.5mg Sublingual Tablet - EU/1/06/359/002
- Suboxone 8mg/2mg Sublingual Tablet - EU/1/06/359/004
- Subutex 2mg Sublingual Tablets - PA22617/001/002
- Subutex 8mg Sublingual Tablets - PA22617/001/003
- Ultiva 1mg Powder for Concentrate for Solution for Infusion - PA1691/032/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Caverject 10mcg Powder and Solvent for Solution for Injection - PA0822/115/002
- Detrunorm XL 30mg Modified-Release Capsules – PA1876/009/001
- Detrunorm XL 45 mg Modified-Release Capsules - PA1876/009/002
- Saline Steri-Neb 0.9% w/v Nebuliser Solution - PA1986/087/001
- Sevelamer Carbonate 800mg Film Coated Tablets - PA0577/205/001
- Skinoren 15% Gel - PA1025/009/001
- Travocort 0.1 + 1% w/w Cream - PA1025/012/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.